Evidence map›Paper›PMID 17898805›Full record

ArticleThe EMBO journal2007

Forkhead proteins control the outcome of transcription factor binding by antiactivation.

Warren P Voth, Yaxin Yu, Shinya Takahata, Kelsi L Kretschmann, Jason D Lieb, Rebecca L Parker, Brett Milash, David J Stillman

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. The Forkhead Box Gene,Journal of fungi (Basel, Switzerland) · 2024
    Article
  4. Unveiling Forkhead-mediated regulation of yeast cell cycle and metabolic networks.Computational and structural biotechnology journal · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Homotypic cooperativity and collective binding are determinants of bHLH specificity and function.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Article
  12. Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. Disruption of promoter memory by synthesis of a long noncoding RNA.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Warren P VothDepartment of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA.
Yaxin Yu
Shinya Takahata
Kelsi L Kretschmann
Jason D Lieb
Rebecca L Parker
Brett Milash
David J Stillman
University of Utah · USUniversity of North Carolina at Chapel Hill · US

Funding

Uniting disparate fields to explore transcription factor binding dynamicsR01GM072518 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIEB, JASON D · 2005 to 2014
$2.5M
PREDOCTORAL TRAINING PROGRAM IN BIOLOGICAL CHEMISTRYT32GM008537 · NIGMS · UNIVERSITY OF UTAH · PI POULTER, CHARLES DALE · 1993 to 2005
$1.4M
NIGMS NIH HHS R01 GM072518NIGMS NIH HHS T32 GM008537NIGMS NIH HHS T32 GM08537
6 · The paper itself

Abstract

Transcription factors with identical DNA-binding specificity often activate different genes in vivo. Yeast Ace2 and Swi5 are such activators, with targets we classify as Swi5-only, Ace2-only, or both. We define two unique regulatory modes. Ace2 and Swi5 both bind in vitro to Swi5-only genes such as HO, but only Swi5 binds and activates in vivo. In contrast, Ace2 and Swi5 both bind in vivo to Ace2-only genes, such as CTS1, but promoter-bound Swi5 fails to activate. We show that activation by Swi5 is prevented by the binding of the Forkhead factors Fkh1 and Fkh2, which recruit the Rpd3(Large) histone deacetylase complex to the CTS1 promoter. Global analysis shows that all Ace2-only genes are bound by both Ace2 and Swi5, and also by Fkh1/2. Genes normally activated by either Ace2 or Swi5 can be converted to Ace2-only genes by the insertion of Fkh-binding sites. Thus Fkh proteins, which function initially to activate SWI5 and ACE2, subsequently function as Swi5-specific antiactivators.

Indexed as

AcetylationCell CycleChromatin ImmunoprecipitationDNADNA-Binding ProteinsForkhead Transcription FactorsFungal ProteinsGene Expression Regulation, FungalHistonesOpen Reading FramesPromoter Regions, GeneticProtein BindingProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription FactorsACE2 protein, S cerevisiaeDNADNA-Binding ProteinsForkhead Transcription FactorsFungal ProteinsHistonesSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID17898805
PMCPMC2034669
OpenAlexW2051435619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.